These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34314480)

  • 21. Novel approach to gene expression profiling in Sézary syndrome.
    Pomerantz RG; Mirvish ED; Erdos G; Falo LD; Geskin LJ
    Br J Dermatol; 2010 Nov; 163(5):1090-4. PubMed ID: 20698843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.
    Boonk SE; Zoutman WH; Marie-Cardine A; van der Fits L; Out-Luiting JJ; Mitchell TJ; Tosi I; Morris SL; Moriarty B; Booken N; Felcht M; Quaglino P; Ponti R; Barberio E; Ram-Wolff C; Jäntti K; Ranki A; Bernengo MG; Klemke CD; Bensussan A; Michel L; Whittaker S; Bagot M; Tensen CP; Willemze R; Vermeer MH
    J Invest Dermatol; 2016 Jul; 136(7):1364-1372. PubMed ID: 26930587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
    Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
    J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of bullous Sézary syndrome.
    Ono A; Isomura I; Isogai Z; Shintani Y; Suzuki A; Morita A
    J Dermatol; 2004 Dec; 31(12):1027-31. PubMed ID: 15801270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
    Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
    J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
    Weng WK; Armstrong R; Arai S; Desmarais C; Hoppe R; Kim YH
    Sci Transl Med; 2013 Dec; 5(214):214ra171. PubMed ID: 24307695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
    Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
    J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It is time to adopt a multicolor immunophenotyping approach to evaluate blood for Sézary syndrome and mycosis fungoides.
    Craig FE
    Cytometry B Clin Cytom; 2021 Mar; 100(2):125-128. PubMed ID: 32083391
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunophenotyping on simultaneously occurring plaques and tumours in mycosis fungoides and Sézary syndrome.
    Preesman AH; Toonstra J; van der Putte SC; van Vloten WA
    Br J Dermatol; 1993 Dec; 129(6):660-6. PubMed ID: 8286248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
    Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA
    Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
    Rasmussen TA; McMahon J; Chang JJ; Symons J; Roche M; Dantanarayana A; Okoye A; Hiener B; Palmer S; Lee WS; Kent SJ; Van Der Weyden C; Prince HM; Cameron PU; Lewin SR
    AIDS; 2017 Aug; 31(13):1839-1845. PubMed ID: 28514279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.
    Balfour EM; Glusac EJ; Heald P; Talley LL; Smoller BR
    J Cutan Pathol; 2003 Aug; 30(7):437-42. PubMed ID: 12859741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
    Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
    Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcoidal tissue reaction in Sézary syndrome.
    Gregg PJ; Kantor GR; Telang GH; Lessin SR; Nowell PC; Vonderheid EC
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):372-6. PubMed ID: 10901727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.
    Scala E; Abeni D; Pomponi D; Narducci MG; Lombardo GA; Mari A; Frontani M; Picchio MC; Pilla MA; Caprini E; Russo G
    Haematologica; 2010 Nov; 95(11):1905-12. PubMed ID: 20663947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.